Press Releases

Advising The Felix Project on its acquisition of FareShare's London operations

London, 17 November 2020 – Hogan Lovells has advised The Felix Project on a pro bono basis on its acquisition of FareShare's London operations. The deal makes Felix, already...

Awards and Rankings

Hogan Lovells listed in The Times Best Law Firms 2021

The Times has listed Hogan Lovells among England and Wales' top law firms in its Best Law Firms guide, for the third consecutive year.

Press Releases

Infringement of a UK Standard Essential Patent does not justify global damages

London, 5 November 2020 – Hogan Lovells has secured an important victory for its client HTC against IPCom in a long-running patent litigation battle. In its judgment handed down...

Awards and Rankings

Hogan Lovells wins in three categories at the ALB Japan Law Awards 2020

After being shortlisted in 10 categories in the 16th Annual Asian Legal Business (ALB) Japan Law Awards 2020, we are delighted to announce our receipt of three awards: Intellectual Property ...

Press Releases

Hogan Lovells commits to global Diversity & Inclusion goals for racial and ethnic minority and LGBT+ partners

London, Washington, D.C., 19 October 2020 – With the full backing of the International Management Committee (IMC) and Board, Hogan Lovells has announced today the introduction of two...

Press Releases

Hogan Lovells advises PTC on the acquisition of ioxp

Led by Munich Partner Nikolas Zirngibl, international law firm Hogan Lovells advised Parametric Technology Holding Germany GmbH, a subsidiary of PTC Inc., on the acquisition of ioxp. The...

Press Releases

Hogan Lovells advises Jennewein shareholders on its dual-track exit

Led by partners Peter Huber and Michael Schlitt, international law firm Hogan Lovells has advised the shareholders of Jennewein Biotechnologie GmbH on its EUR 310 million merger with Danish ...

Press Releases

Eli Lilly secures major win in its long-running patent dispute with Fresenius Kabi over oncology drug Alimta

London, Paris, 16 September 2020 –  Eli Lilly has secured a major win in its long-running patent dispute with Fresenius Kabi over oncology drug Alimta. Eli Lilly was represented...

Loading data